Jobs with Startups
JobsStartupsInvestorsMCP
Startups

Vivodyne

Vivodyne logo

Vivodyne

Human organ-on-chip platform for drug discovery.

vivodyne.com
HQ: San Francisco, CA, USA
Biotech

Company research

Public company, workplace, funding, and market signals

Updated Aug 16, 2026

Overview

Vivodyne is a biotechnology research company that builds predictive human-data platforms for drug discovery and development using lab-grown 3D human tissues, robotics, and AI to generate preclinical human data before clinical trials.

Primary product

A robotics + AI platform for scalable testing on lab-grown human tissues / human organ models for preclinical drug discovery and development.

Founded

2020

Headquarters

San Francisco, California, United States

Team size

30-40

Industry

Biotechnology Research

Sub-industry

Preclinical drug discovery / human tissue engineering / organ-on-chip / bio-AI

Offices

Philadelphia, Pennsylvania, United States
Brisbane/South San Francisco Bay Area, California, United States

Business model

B2B
platform
services

Funding

Stage

Series A

Total raised

$80M

Latest round

Series A · May 2025

Latest amount

$40M

Series A

May 2025 · Khosla Ventures

$40M

Seed

Nov 2023 · Khosla Ventures

$38M

People & investors

Leadership

Andrei Georgescu

CEO / Co-Founder

Dan Huh

CSO / Co-Founder

Julie O’Shaughnessy

Chief Operating Officer

Anthony Bahinski

Chief Biotechnology Officer

Sanja Menicanin

VP of Product

Andrew McFarland

VP of Hardware and Automation

Lisa Alpert

Senior Manager Business Operations

Alex Stankiewicz

Scientific Strategy & Business Development

Benjamin Dobkin

Senior Director, Business Development

Jonathan Galarraga

Senior Director, Tissue Development

Founders

Andrei Georgescu, Ph.D.

CEO / Co-Founder

Dan Huh, Ph.D.

CSO / Co-Founder

Investors

Bison Ventures
CS Ventures
Fortius Ventures
Helena Capital
Kairos Ventures
Khosla Ventures
Lingotto Investment Management
MBX Capital

Work & culture

Public materials emphasize ambitious, mission-driven work at the intersection of biology, robotics, and AI, with a focus on building a high-performance team. No detailed public benefits package was found.

Compensation

No public compensation bands were found in the searched primary sources and company pages.

Product & market

Pricing

Not publicly disclosed; likely enterprise platform/service contracts for pharma and biotech customers.

Differentiators

  • —Uses perfusably vascularized, lab-grown human tissues rather than traditional organoids alone
  • —Automated robotics stack enables high-throughput experimentation at scale
  • —Generates multi-omic human data for predictive modeling before clinical trials
  • —Positioned as an alternative to less predictive animal testing
  • —Broad tissue/model portfolio spanning the preclinical pipeline

Technology

python
git
matlab
linux
unix
javascript
nextflow
react
typescript
mlops
solidworks
confluence
jira
nvidia
ansys
mongodb
kuka
cuda
unity
docker

Customers

Most top pharmaceutical companies
Global pharmaceutical clients

Competitors

Emulate
CN Bio
Hesperos
Mimetas
TissUse
Recursion

Scale & contact

Estimated revenue

$1M-$10M

Estimated monthly visits

2.7K

Traffic estimate as of Jun 2026

Latest news

The most innovative biotech companies of 2026

Fast Company · Mar 2026

Fast Company named Vivodyne one of the most innovative biotech companies of 2026, citing its automated biological data centers that test 10,000 human tissues at once and its use by top pharmas such as GSK.

Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform

Penn Center for Innovation · Jul 2025

University-affiliated source confirming Vivodyne’s Penn roots and the financing to scale its platform.

Vivodyne raised $40 million from Khosla Ventures and others

The Philadelphia Inquirer · Jun 2025

Confirms the new round, prior $38M raise, headcount around 40, and expansion plans in South San Francisco.

Vivodyne Secures $40M Series A to Scale AI-Powered Human Tissue Testing

Hit Consultant · May 2025

Summarizes the funding and expansion into a new robotic lab facility.

Vivodyne raises $40 million in funding round led by Khosla Ventures

Axios · May 2025

Axios reported the round and highlighted Vivodyne’s San Francisco base and its use of lab-grown human tissues for drug discovery and development.

About Us / TeamAndrei Georgescu LinkedInBlogCareersContactContact UsDan Huh LinkedInGitHub (related account)HomeHomepage
SourcesVivodyne homepageVivodyne About UsVivodyne TeamVivodyne BlogVivodyne ContactVivodyne Contact UsVivodyne LinkedIn companyAndrei Georgescu LinkedInDan Huh LinkedInBusiness Wire Series A announcement

Jobs and careers at Vivodyne

6 jobs at Vivodyne

Senior Engineer, Microfluidics & Applications

On-site
Hardware + Automation
San Francisco (Brisbane), CA; San Francisco, California, United States
1w ago
On-site
Full-time
Apply

Senior Program Manager, Client Delivery

On-site
Operations
San Francisco (Brisbane), CA; San Francisco, California, United States
1w ago
On-site
Full-time
Apply

Senior Bioinformatician

On-site
AI + Data Science
San Francisco (Brisbane), CA; San Francisco, California, United States
1mo ago
On-site
Full-time
Apply

Lab Operations Specialist

On-site
Operations
Philadelphia, PA
2mo ago
On-site
Full-time
Apply

Senior Full Stack Software Engineer

On-site
Software
San Francisco (Brisbane), CA
4mo ago
On-site
Full-time
Apply

AI Senior Scientist

On-site
AI + Data Science
San Francisco (Brisbane), CA
9mo ago
On-site
Full-time
Apply

Explore startup hiring

Startup Hiring PulseBrowse all startup jobsJobs at early-stage startupsJobs at venture-backed startups

Jobs with Startups © 2026

Browse jobsMCP guideAboutPowered by Supabase